Preview

Neurology, Neuropsychiatry, Psychosomatics

Advanced search

The level of interleukin-6 in acute ischemic stroke: effect on the rate of recovery in patients and on the severity of neurological defect

https://doi.org/10.14412/2074-2711-2018-3-29-35

Full Text:

Abstract

Interleukin 6 (IL-6) plays an important role in the pathogenesis of ischemic stroke (IS), exerting a modulating effect on a number of processes that determine the outcome of this disease. Objective: to investigate the peripheral blood levels of IL-6 in patients in the acute period of different IS pathogenetic subtypes and its effect on recovery rates. Patients and methods. The study enrolled 155 patients (74 men and 81 women; mean age, 63.8 years). A control group consisted of 28 people without IS. Pathogenetic subtype II was established in accordance with the TOAST (Trial of Org 10172 in Acute Stroke Treatment) criteria on the basis of their clinical picture and the data of computed tomography or magnetic resonance imaging and ultrasonography of the main arteries of the head. The severity of a patient's condition and a focal neurological defect and the time course of clinical changes after stroke were determined using the National Institutes of Health Stroke Scale (NIHSS). An enzyme immunoassay (EIA) was used to measure IL-6 levels on days 1, 7, and 21 after onset of IS. An enzyme immunoassay (EIA) was used to measure IL-6 levels on days 1, 7, and 21 after onset of IS. Results. In the acute period of IS, there were significantly elevated levels of IL-6. The latter reached its highest values on day 7 in patients with the atherothrombotic pathogenetic subtype of IS. On day 7 of the study, the peak concentration of IL6 was typical for patients with all subtypes of IS, except for lacunar stroke. After its increase on day 1 of the study, the IL6 level in patients with lacunar stroke did not change significantly in all other periods. In acute IS, the concentration of IL-6 was significantly influenced by the following cardiovascular risk factors: hypercholesterolemia of days 1, 7 (p<0.01) and 21 (p<0.05), hypertension in day 1 (p<0.05), diabetes mellitus on days 1 and 7 (p<0.05), and coronary heart disease in all the study periods (p<0.01). The IL-6 concentration significantly correlated with the severity of neurological defect, but did not significantly affect the rate of recovery in the patient with acute IS. Conclusion. IL-6 was established to be of prognostic value for the outcome of acute IS on day 7. The rate of recovery can be used to identify targets for therapeutic intervention.

About the Authors

S. P. Sergeeva
I.M. Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of Russia, Moscow
Russian Federation


А. А. Savin
A.I. Evdokimov Moscow State University of Medicine and Dentistry, Ministry of Health of Russia, Moscow
Russian Federation


I. D. Breslavich
I.M. Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of Russia, Moscow
Russian Federation


P. F. Litvitsky
I.M. Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of Russia, Moscow
Russian Federation


V. V. Arkhipov
I.M. Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of Russia, Moscow
Russian Federation


References

1. Парфенов ВА, Хасанова ДР. Ишемический инсульт. Москва: МИА; 2012:288 [Parfenov VA, Khasanova DR. Ischemicheskiy insul’t [Ischemic stroke]. Moscow: MIA; 2012. 288 p.]

2. Lakhan SE, Kirchgessner A, Hofer M. Inflammatory mechanisms in ischemic stroke: therapeutic approaches. J Transl Med. 2009 Nov 17;7:97. doi: 10.1186/1479-5876-7-97.

3. Waje-Andreassen U, Krakenes J, Ulvestad E, et al. IL-6: an early marker for outcome in acute ischemic stroke. Acta Neurol Scand. 2005 Jun; 111(6):360-5.

4. Kwan J, Horsfield G, Bryant T, et al. IL-6 is a predictive biomarker for stroke associated infection and future mortality in the elderly after an ischemic stroke. Exp Gerontol. 2013 Sep;48(9): 960-5. doi: 10.1016/j.exger.2013.07.003. Epub 2013 Jul 17.

5. Ballesteros I, Cuartero MI, Pradillo JM, et al. Cytokines and Chemokines in Stroke. In: Caplan LR, Biller J, Leary MC, et al, editors. Primer on Cerebrovascular Diseases (2nd Edition). San Diego: Academic Press; 2017. P. 280-4.

6. Borsini A, Zunszain PA, Thuret S, Pariante CM. The role of inflammatory cytokines as key modulators of neurogenesis. Trends Neurosci. 2015 Mar;38(3):145-57. doi: 10.1016/j.tins.2014.12.006. Epub 2015 Jan 8.

7. Bakhshi H, Ostovaneh MR, Venkatesh BA, et al. Abstract 14731: Association of Longitudinal Changes in CRP, IL-6, and Fibrinogen Level With Cardiovascular Disease Events: The Multi-Ethnic Study of Athero-+ sclerosis (MESA). Circilation. 2015;132(Suppl 3): A14731.

8. Hartman J, Frishman WH. Inflammation and atherosclerosis: a review of the role of interleukin-6 in the development of atherosclerosis and the potential for targeted drug therapy. Cardiol Rev. 2014 May-Jun;22(3):147-51.

9. doi: 10.1097/CRD.0000000000000021.

10. Adams HP, Bendixen BH, Kappelle LJ, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke. 1993 Jan;24(1):35-41.

11. Brott T, Adams HP, Olinger CP, et al. Measurements of acute cerebral infarction: a clinical examination scale. Stroke. 1989 Jul; 20(7):864-70.

12. Руженков ВА, Руженкова ВВ. Некоторые аспекты терминологии и классификации аутоагрессивного поведения. Суицидология. 2014;5.1(14):41-51. [Ruzhenkov VA, Ruzhenkova, VV. Some aspects of terminology and classification of self-injurious behavior. Suitsidologiya. 2014;5.1(14):41-51. (In Russ.)].

13. Brambilla R, Couch Y, Lambertsen KL. The effect of stroke on immune function. Mol Cell Neurosci. 2013 Mar;53:26-33. doi: 10.1016/j.mcn.2012.08.011. Epub 2012 Aug 30.

14. Trakhtenberg EF, Goldberg JL. Neuro immune communication. Science. 2011 Oct 7;334(6052):47-8. doi: 10.1126/science. 1213099.

15. Wang J, Yu L, Jiang C, et al. Cerebral ischemia increases bone marrow CD4+ CD25+ FoxP3+ regulatory T cells in mice via signals from sympathetic nervous system. Brain Behav Immun. 2015 Jan;43:172-83. doi: 10.1016/j.bbi.2014.07.022. Epub 2014 Aug 7.

16. Rosas-Ballina M, Olofsson PS, Ochani M, et al. Acetylcholine-synthesizing T cells relay neural signals in a vagus nerve circuit. Science. 2011 Oct 7;334(6052):98-101. doi: 10.1126/ science.1209985. Epub 2011 Sep 15.

17. Jickling GC, Liu D, Ander BP, et al. Targeting neutrophils in ischemic stroke: translational insights from experimental studies. J Cereb Blood Flow Metab. 2015 Jun;35(6):888-901. doi: 10.1038/jcbfm.2015.45. Epub 2015 Mar 25.

18. Shim R, Wong CHY. Ischemia, immunosuppression and infection-tackling the predicaments of post-stroke complications. Int J Mol Sci. 2016 Jan 5;17(1). pii: E64. doi: 10.3390/ ijms17010064.

19. Offner H, Subramanian S, Parker SM, et al. Experimental stroke induces massive, rapid activation of the peripheral immune system. J Cereb Blood Flow Metab. 2006 May;26(5):654-65.

20. Taleb S. Inflammation in atherosclerosis. Arch Cardiovasc Dis. 2016 Dec;109(12):708-715. doi: 10.1016/j.acvd.2016.04.002. Epub 2016 Aug 29.

21. Koloverou E, Panagiotakos D, Chrysohoou C, et al. Single and combined effects of inflammatory markers on diabetes development; the mediating role of obesity: 10-year follow up of the Attica study. Clin Nutr ESPEN. 2018 Apr;24:180. doi: 10.1016/j. clnesp.2018.01.034. Epub 2018 Mar 22.


For citation:


Sergeeva S.P., Savin А.А., Breslavich I.D., Litvitsky P.F., Arkhipov V.V. The level of interleukin-6 in acute ischemic stroke: effect on the rate of recovery in patients and on the severity of neurological defect. Neurology, Neuropsychiatry, Psychosomatics. 2018;10(3):29-35. (In Russ.) https://doi.org/10.14412/2074-2711-2018-3-29-35

Views: 173


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2074-2711 (Print)
ISSN 2310-1342 (Online)